Discover more from Courageous Discourse™ with Dr. Peter McCullough & John Leake
Systematic Review of Published COVID-19 Vaccine Serious Adverse Events
2021 Reports Summarize a Cardiovascular, Thromboembolic Safety Disaster
By Peter A. McCullough, MD, MPH
While many have argued that the public health voluntary adverse event reporting systems represent under-reporting and give scan clinical information, the safety results being published in the peer-reviewed literature cannot be easily dismissed. Despite tremendous editorial bias resulting in rejection of manuscripts on vaccine safety events, the papers that survive to publication tell us just a small fraction of the story.
Yasmin et al reported from 2021 alone, a stunning number of papers with cases describing nothing short of a cardiovascular safety disaster.
A total of 81 articles on COVID-19 mRNA vaccines in 17,636 individuals and reported 284 deaths with any mRNA vaccine. Of 17,636 cardiovascular events with any mRNA vaccine, 17,192 were observed with the BNT162b2 (Pfizer-BioNTech) vaccine, 444 events with mRNA-1273 (Moderna). Thrombosis was frequently reported with any mRNA vaccine (n = 13,936), followed by stroke (n = 758), myocarditis (n = 511), myocardial infarction (n = 377), pulmonary embolism (n = 301), and arrhythmia (n = 254). The time between the vaccination dosage and the first symptom onset averaged 5.6 and 4.8 days with the mRNA-1273 vaccine and BNT162b2, respectively.
Keep in mind usually < 50 deaths with a widely used, novel product prompts a worldwide recall. To have 284 well described deaths as a result of cardiovascular and or thrombotic complications is a striking finding in the medical literature for products that are still on the market and promoted by public health agencies all over the world.
The wide range of therapeutics used to treat vaccine injury syndromes indicates there are no simple solutions. We use the drugs disclosed by Yasmin et al in clinical practice, but importantly, have found McCullough Protocol Base Spike Protein Detoxification to be a key basis of support in order to aid in elimination of vaccine Spike protein and ultimately restore the patient to good health. Our goal with this protocol widely applied to the at-risk population is to prevent cardiovascular and thromboembolic complications in those who have had multiple episodes of COVID-19 and or taken mRNA vaccines.
So the next time someone attempts to promote the false “safe and effective” narrative. Feel free to cite this paper that makes the case the vaccines are simply not safe for human use.
Please subscribe to Courageous Discourse as a paying or founder member so we can continue to bring you the truth.
Courageous Discourse™ with Dr. Peter McCullough & John Leake is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
Peter A. McCullough, MD, MPH
President, McCullough Foundation
Yasmin F, Najeeb H, Naeem U, Moeed A, Atif AR, Asghar MS, Nimri N, Saleem M, Bandyopadhyay D, Krittanawong C, Fadelallah Eljack MM, Tahir MJ, Waqar F. Adverse events following COVID-19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia. Immun Inflamm Dis. 2023 Mar;11(3):e807. doi: 10.1002/iid3.807. PMID: 36988252; PMCID: PMC10022421.